Edward Smith
Pediatrics · Durham, NCNPI 1881897361
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Catalyst Pharmaceuticals, Inc. at 34.2% of the total. Among pediatrics clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 245 payments — averaging $670.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Catalyst Pharmaceuticals, Inc.$56K
- Sarepta Therapeutics, Inc.$45K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$20K
- Pfizer$15K
- Biogen$14K
- Genentech USA, Inc.$5K
- plus $9K from 10 others
Across 346 payments — averaging $7580.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.3M
- Biogen$383K
- Ultragenyx Pharmaceutical Inc.$333K
- Sarepta Therapeutics, Inc.$208K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$169K
- NS Pharma, Inc.$97K
- plus $86K from 3 others
What the payments were for
- Consulting fees$80,29349%
- Speaking & faculty fees$51,57031%
- Travel & lodging$14,4609%
- Food & beverage$5,6213%
- Education$12,3538%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Catalyst Pharmaceuticals, Inc. | 49 | $56,194 |
| Sarepta Therapeutics, Inc. | 59 | $44,772 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 60 | $20,397 |
| Pfizer | 18 | $15,362 |
| Biogen | 32 | $14,112 |
| Genentech USA, Inc. | 2 | $4,665 |
| Vertex | 5 | $2,272 |
| Daiichi Sankyo Inc. | 2 | $2,243 |
| NS Pharma, Inc. | 2 | $1,876 |
| Eli Lilly | 2 | $1,125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $808 |
| AstraZeneca | 1 | $150 |
| Novartis | 1 | $137 |
| Genentech, Inc. | 2 | $131 |
| Biomarin Pharmaceutical Inc. | 1 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$164,297 in reported general payments places this provider in the 95th percentile of 1,818 pediatrics providers in North Carolina.
Other pediatrics in Durham
- Dwight KoeberlDurham$8.4M
- Priya KishnaniDurham$5.8M
- Daniel LandiDurham$70K
- Rasheed GbadegesinDurham$50K
- Mohamad MikatiDurham$35K
- David VanmaterDurham$32K
- Stephanie DearmeyDurham$30K
- Emmanuel WalterDurham$15K
- William MalcolmDurham$14K
- Charlene WongDurham$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.